As a seasoned obstetrician with over a decade of experience practicing in Canada, I've witnessed firsthand the challenges faced by healthcare professionals during childbirth. Today, I'm excited to introduce you to a groundbreaking solution that will revolutionize perineal surgery – the BIOS shelf.
The Problem:
Each year, millions of mothers in the United States undergo natural childbirth, but unfortunately, many of them suffer from perineal lacerations, complicating what should be a joyous occasion. Repairing these injuries is often laborious and time-consuming for obstetricians, leading to inefficiencies in patient care and increased risk of complications.
The Solution:
The BIOS shelf is a meticulously designed surgical device aimed at streamlining perineal surgeries. It offers a convenient platform for holding instruments directly in front of surgeons, enhancing precision and efficiency during procedures. This innovative tool promises to transform how obstetricians and other surgeons approach perineal repairs, ultimately improving patient outcomes.
Market Opportunity:
In the US alone, there were over 3.75 million natural deliveries last year, representing a significant market for our device. With conservative estimates suggesting a potential market of 102,000 deliveries annually, the demand for the BIOS shelf is undeniable. Furthermore, its applications extend beyond obstetrics to include colorectal surgery, urogynecology, urology, and general surgery, further expanding our addressable market.
Validation and Testimonials:
Feedback from leading healthcare professionals underscores the value of the BIOS shelf:
"I like it... simple in design and allows for a more efficient and ergonomic way to approach repairing perineal injuries." – Obstetrician
"I saw your videos and very much like your product. I would like to trial it as I do a lot of anorectal surgery." – Colorectal Surgeon
Financial Needs and Timeline:
To bring the BIOS shelf to market, we're seeking $100,000 in funding. These funds will be allocated towards FDA clearance, product validations, biocompatibility testing, and manufacturing. With an experienced team and strategic partnerships in place, we anticipate obtaining FDA approval within six months, paving the way for commercialization.
Financial Projections:
Based on conservative estimates, capturing just 5% of the US market translates to 5,000 devices annually, with the potential for significant growth. Our manufacturing partners have projected a production cost of $4.50 per unit, ensuring healthy profit margins. With a retail price target of $40 per device, the revenue potential is substantial.
Equity Offering:
In exchange for your investment, we're offering a 25% equity stake in our startup. We're confident that this partnership will yield mutually beneficial returns as we work together to capitalize on this exciting opportunity.
Conclusion:
Thank you for considering this investment opportunity. The BIOS shelf represents not only a lucrative business venture but also a chance to make a meaningful impact on healthcare delivery worldwide. I look forward to discussing how we can collaborate to bring this innovative device to market successfully
